Johnson & Johnson should pay a South Dakota nurse $3.35 million according to the jury in the much-reported vaginal mesh trial. They found that the company had failed to provide adequate warning to the plaintiff’s doctor of the potential dangers posed by a vaginal mesh implant made by its Ethicon subsidiary. The company was also found to have misrepresented the product in brochures.
According to a news release by Reuters, this was the first verdict among some 1,800 vaginal mesh cases pending in New Jersey against Ethicon, Inc. and J&J, and could impact thousands of lawsuits against other manufacturers of vaginal mesh implants, including Boston Scientific. J&J has posted a regulatory filing on its website this week, which suggests that it is prepared for as many as 4000 plaintiffs with direct claims in pending lawsuits regarding pelvic mesh products.
What happens next is that J&J has the right of rebuttal and is reportedly likely to use it. A spokesman for the company told US news site Massdevice that; “While we are always concerned when a patient experiences medical conditions like those suffered by the plaintiff, all surgeries for pelvic organ prolapse present risks of complications.”
Source: Reuters, MassDevice